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Nipple discharge is a common symptom that is alarming for the patient since it can be 
a presenting symptom of breast cancer. Breast imaging is used to examine women with 
pathologic nipple discharge in order to detect any lesions that may be present and to assist 
in the differential diagnosis. The modalities of breast imaging include mammography, breast 
ultrasonography (US), and magnetic resonance imaging. Breast US is currently considered to 
be useful for the visualization of ductal structures and intraductal lesions that cause nipple 
discharge. In this review, we discuss US techniques that assist in the clear visualization of 
ductal structures and intraductal lesions in patients with nipple discharge. Controversy remains 
regarding the evaluation and management of patients with nipple discharge, and we summarize 
the results available in the currently published literature. 
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Introduction
Nipple discharge accounts for 2%-10% of the symptoms that women report when they seek care 
at breast clinics [1,2] and is alarming for both patients and clinicians since it is a presenting sign 
of breast cancer. Nipple discharge can result from various physiologic or pathologic causes, and 
accurately identifying the causative condition is critical for patient management. Despite the anxiety 
it causes, most underlying causes of nipple discharge are benign, as the cancer rate in patients with 
nipple discharge has been reported to be 5%-21.3% [1,3-5]. A thorough investigation of the patient 
is warranted, with a physical examination and breast imaging to accurately distinguish patients who 
require surgical treatment for breast cancer from those who may be managed conservatively. Herein, 
we review the causes of nipple discharge, the ultrasonographic (US) imaging techniques used to 
evaluate the cause of nipple discharge, and the management of patients with nipple discharge.
Pathogenesis of Nipple Discharge
Nipple discharge is defined as a true, direct drainage from the mammary ducts that grossly appears 
at the surface of the nipple [2]. Grossly apparent nipple discharge is due to (1) excess secretions 
due to physiologic or hormonal causes, or (2) obstructive breast masses or lesions located within 
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the ductal structures that either block the ductal drainage system 
or independently cause excess secretions within the duct (Fig. 
1). Based on its origin, nipple discharge can be categorized as 
physiologic or pathologic discharge. Physiologic nipple discharge 
includes galactorrhea following normal hormonal stimulation during 
pregnancy or lactation. This condition can persist for more than 1 
year after discontinuing breast feeding. Other than pregnancy or 
lactation, elevated levels of prolactin or thyroid-stimulating hormone 
can induce galactorrhea, and the clinician should determine whether 
underlying conditions causing these hormonal abnormalities are 
present. 
Pathologic nipple discharge is defined as spontaneous, unilateral, 
bloody, or serous discharge, often arising from a single duct [1]. 
Common causes for pathologic nipple discharge are intraductal 
papilloma, duct ectasia, inflammation, and breast cancer, among 
which intraductal papilloma is most common, accounting 
for approximately 57% of cases [1]. Table 1 summarizes the 
characteristics of physiologic and pathologic nipple discharge. 
Evaluation of Patients with Nipple Discharge
With the exception of physiologic galactorrhea seen in pregnant or 
lactating women, a thorough investigation of the cause of nipple 
discharge must be performed. A detailed history including the 
patient’s medical history and a physical examination evaluating the 
characteristics of the nipple discharge should be carried out as the 
first step; this is important, because these steps provide information 
useful for characterizing the nipple discharge and deciding upon the 
next step in patient management. A physical examination is needed 
to locate breast masses associated with the nipple discharge. If 
the discharge is considered to be physiologic based on the clinical 
information and characteristics of the nipple discharge, no further 
imaging studies of the breast are warranted if the patient is under 
the age of 40 years or over 40 years with up-to-date routine 
screening mammography. If the discharge is considered to be 
pathologic, all women should have breast imaging examinations, 
regardless of age (Fig. 2). 
Imaging Workup
Approximately 80%-90% of patients with pathologic nipple 
discharge have been reported to have benign conditions [1,3-6], 
but since the risk of breast cancer cannot be completely excluded, 
surgical duct excision is commonly considered. Breast imaging is 
used to evaluate women with pathologic nipple discharge for two 
common purposes: first, to localize the lesion that can explain the 
origin of the pathologic nipple discharge, and second, to determine 
whether the pathologic nipple discharge is caused by a cancerous 
lesion. Several reports have proven that mammography and breast 
US are useful for detecting the pathologic causes of nipple discharge 
[3,7], and especially for detecting findings indicative of breast 
cancer. Still, controversy remains regarding whether breast imaging 
helps in triaging patients who need immediate surgical intervention 
from those who can be managed conservatively, but in general 
the role of breast imaging is being increasingly emphasized for the 
following reasons. First, breast imaging enables the localization of 
the breast abnormalities causing the pathologic nipple discharge, 
which helps to minimize the number of operations and/or the 
extent of surgery. Second, localizing the origin of pathologic nipple 
discharge enables percutaneous biopsy under imaging guidance, 
Fig. 1. Pathogenesis of pathologic nipple discharge. Other than 
physiologic causes, obstructive lesions in the breast that either 
block the ductal drainage system (A) or independently form excess 
secretions within the central (B) or peripheral ductal system (C, 
dotted circle) are common causes of nipple discharge.
Table 1. Comparison of the characteristics of physiologic and 
pathologic nipple discharge
Characteristic
Physiologic nipple 
discharge
Pathologic nipple 
discharge
Manifestation Bilateral Unilateral 
Multiple ducts Single duct
Resolves spontaneously Intermittent, persistent
Color Clear or white, yellow, 
green, brown, gray
Bloody, serous 
Blood tests Negative, regardless of 
color 
Positive
Causes Pregnancy/lactation Intraductal papilloma
Nipple stimulation/breast 
compression
Duct ectasia
Endocrine abnormalities Mastitis
Medications Breast cancer
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based on ductographic findings alone [10,11]. Several studies have 
proposed applying breast magnetic resonance imaging (MRI) to 
evaluate patients who have pathologic nipple discharge, especially 
in patients who have negative findings on mammography or US 
[7,12-14], but the usefulness of MRI is limited by the fact that it 
is very expensive, not readily available in all areas, and requires 
contrast media injection. 
Breast US in Women with Nipple Discharge
Breast US is used as an adjunct to mammography for breast 
imaging, enabling the further characterization of abnormalities 
detected on mammography and providing biopsy guidance. With 
recent improvements in technology, US is particularly useful 
in women with pathologic nipple discharge, since it enables 
the visualization of ductal pathologies that are smaller than a 
centimeter, as well as associated ductal changes that cannot 
be detected on mammography, especially in women with dense 
breasts [1,5,9,13]. For women with pathologic nipple discharge, US 
enables detection of the causative lesion(s), along with orientation 
of the surrounding ductal structures involved, which is helpful in 
planning the method of biopsy or the extent of surgery. Although 
mammography is recommended for women over 40 years old who 
exhibit pathologic nipple discharge, a recent study showed that 
adding US to diagnostic mammography can help detect additional 
which allows clinicians to be more confident when deciding upon 
management, and in particular when choosing whether to perform 
minimally invasive percutaneous vacuum-assisted excision in these 
patients. 
Imaging Modalities Used for Women with Nipple Discharge
The imaging findings associated with pathologic nipple discharge 
may vary according to its origin and the imaging modality applied. 
Among the common imaging modalities currently available for 
breast imaging, mammography is commonly recommended for 
women presenting with nipple discharge. Mammography can reveal 
masses, microcalcifications, and architectural distortions that may be 
associated with the underlying pathologic cause of nipple discharge. 
However, the sensitivity of mammography in detecting the lesion 
causing the pathologic nipple discharge is very low [6,7], since 
intraductal masses or masses in the subareolar region tend to be 
small and lack microcalcifications, in addition to the fact that the 
subareolar region normally shows increased density that can easily 
[7]. Ductography and galactography have been used in the past to 
visualize the number, location, and extent of the involved milk ducts 
in women with pathologic nipple discharge [5,8,9], but ductography 
is an invasive imaging method that requires iodinated contrast 
media injection, and also has low diagnostic accuracy since the 
differential diagnosis of the causative lesion cannot be completed 
Fig. 2. Workflow for the evaluation of women with nipple discharge. TSH, thyroid-stimulating hormone; US, ultrasonography; MRI, 
magnetic resonance imaging.
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Biopsy Breast MRI or
surgical excision
Physiologic Pathologic
Mammography 
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cancers in women with pathologic nipple discharge [4]. Also, the 
addition of US in patients with pathologic nipple discharge who 
had negative findings on mammography led to the detection 
of malignancies in 15.1% of these patients by US-guided core 
needle biopsy, without additional diagnostic surgery [15]. Applying 
subareolar US in patients with pathologic nipple discharge has also 
eliminated ductography from diagnostic evaluations [6,16], since US 
is a less invasive imaging method that is more comfortable for the 
patient and involves no radiation exposure, while showing similar 
diagnostic performance to ductography [7]. The findings in the 
literature regarding the diagnostic performance of mammography, 
US, and breast MRI in patients with pathologic nipple discharge are 
summarized in Table 2. 
Interpretation of Causative Lesions Detected 
on Breast US
In patients with grossly apparent pathologic nipple discharge, 
localizing the breast mass causing the nipple discharge and 
evaluating the ductal structures involved with, surrounding, or 
connected to the causative mass is important for planning the extent 
of surgery or the further management of the patient. According to 
the American College of Radiology Breast Imaging Reporting and 
Data System (ACR BI-RADS) [17], various US features are used for 
describing and differentiating benign and malignant breast lesions. 
The ACR BI-RADS categorizes duct changes as “associated features,” 
and abnormal duct changes are defined as (1) cystic dilatation of 
duct/ducts containing irregular calibers or branching; (2) extension 
Table 2. Diagnostic performance of mammography, US, and MRI in the diagnosis of breast cancer among women with pathologic 
nipple discharge
Study
Mammography US MRI
SEN SPE PPV NPV SEN SPE PPV NPV SEN SPE PPV NPV
Yoon et al. [4], 2015 67.9 90.3 65.5 91.2 82.4 55.5 27.7 93.8 - - - -
Cabioglu et al. [5], 2003 68.4 75.7 41.9 90.3 80 61.2 37.8 90.9 - - - -
Ashfaq et al. [6], 2014 22 94 15 - 100 73 17 - 50 57 25 -
Bahl et al. [7], 2015 56 75 29 90 15 98 58 86 - - - -
Adepoju et al. [13], 2005 10 94 18 88 36 68 14 89 - - - -
Dolan et al. [20], 2010 60 99.4 - - 65 99.6 - - - - - -
Blum et al. [8], 2015 - - - - 43 31 8 79 - - - -
Values are presented as percentage. 
US, ultrasonography; MRI, magnetic resonance imaging; SEN, sensitivity; SPE, specificity; PPV, positive predictive value; NPV, negative predictive value. 
Fig. 3. Ultrasonography of abnormal duct changes defined in the “associated features” of the ACR BI-RADS lexicon for breast 
ultrasonography. 
Abnormal duct changes are defined as (1) cystic dilatation of duct/ducts (A, arrows) containing irregular calibers or branching (B, arrows), 
A B
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C D
Mass
Nipple
Fig. 3. (2) extension of dilated ducts from a malignant mass (C, arrows), or (3) the presence of an intraductal mass, thrombus, or debris (D, 
asterisk). ACR BI-RADS, American College of Radiology Breast Imaging Reporting and Data System.
Fig. 4. Applying different angles during ultrasonography scanning for ductal orientation. 
If an intraductal lesion (arrows) is suspected on either transverse or longitudinal scans (A, B), radial scans obtained by positioning the 
ultrasonography probe parallel to the longitudinal plane of the intraductal lesion (D) show the extent of the involved duct and the connection 
towards the nipple (C, arrow). 
C D
A B
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of dilated ducts from a malignant mass; or (3) the presence of an 
intraductal mass, thrombus, or debris (Fig. 3) [17]. Among the duct 
changes, intraductal masses are at present recommended to be 
assessed as category 4a, indicating a need for biopsy because these 
intraductal masses have an 8% risk of malignancy [17-19]. Still, 
it is not clear whether all intraductal masses should be biopsied, 
and considerable overlap is seen between benign and malignant 
intraductal masses, as demonstrated in a recent study [18]; although 
none of the intraductal masses that only partially filled the duct 
were proven to be cancers, approximately 92% of the intraductal 
masses that completely filled the duct were likewise shown to be 
benign. In addition, in cases when irregular masses show intraductal 
extension, a precise description of the extent of the surrounding 
ductal structures in addition to the irregular mass is required, 
because these ductal extensions often represent ductal carcinoma in 
situ components surrounding an invasive carcinoma. For intraductal 
masses, a description of the length of the duct segment containing 
the mass or debris, the size of the intraductal mass, and the distance 
from the nipple are important factors that are required in US reports. 
Tips on Identifying Causes of Nipple Discharge 
Using Breast US
In patients with pathologic nipple discharge, US is capable of 
visualizing ductal structures located in the subareolar region that 
can be easily obscured on mammography in patients with dense 
breasts. One drawback of breast US is that it is operator-dependent, 
and visualization of the subareolar portion of the breast can be 
difficult, requiring experience in breast imaging. Ductal diseases are 
a major challenge in terms of diagnostic imaging, since visualizing 
ductal structures is particularly difficult, especially if the pathologic 
entity involves small distal ducts, and does not produce sufficient 
C D
Fig. 5. Radial scans for evaluating the extent of the ductal structures involved. 
With the probe in the radial plane (A), the intraductal mass causing the nipple discharge is located, along with the dilated ducts extending 
towards the nipple (B, arrow). By rotating the probe in a clockwise/counterclockwise direction (C), the associated minor ductal structures can 
be visualized (D, arrows) along with the full extent of the diseased duct (D, dotted circle). 
A B
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bending the nipple to the other side (Fig. 6). 
       
Rolled-Nipple Technique 
While the peripheral compression technique involved bending the 
nipple with the transducer, the rolled-nipple technique requires 
manual compression by the performer. As the targeted duct is 
localized with the transducer positioned parallel to its long axis, 
the index finger of the free hand of the performer is positioned at 
the nipple, opposite from the transducer. By sliding the transducer 
towards the nipple, the nipple is gradually rolled over the index 
finger, producing firm adherence of the probe to the skin and 
flattening out the area that needs visualization (Fig. 7). When 
using this technique, performers must be cautious to apply light 
compression with the transducer to avoid collapsing the dilated 
ductal structures. 
Two-Handed Compression Technique 
Intraductal lesions often produce secretions that fill up the ducts, 
causing duct dilatation and nipple discharge. On breast US, these 
secretions appear as echogenic material within the ducts, mimicking 
intraductal solid masses. The two-handed compression technique is 
useful in differentiating intraductal debris from true masses, as the 
external compression can collapse ducts containing only secretory 
material, but not ducts containing masses. With the transducer 
material to dilate the ducts. Adding to this, the acoustic shadowing 
that is commonly seen beneath the nipple-areolar complex due to 
the gathering of the major ducts, the uneven skin surfaces of nipple-
areolar complex, or the protuberance of the nipple itself interferes 
with clear visualization of the ductal structures. 
Radial Scans
Applying the US probe at different angles helps to accurately 
detect the intraductal mass and/or to delineate the ductal structure 
involved. When an intraductal lesion is suspected, radial scans are 
helpful in visualizing the extent and direction of the duct involved, 
by positioning the US probe parallel to the long axis of the detected 
intraductal lesion (Fig. 4). Additionally, radial scans are helpful in 
detecting the ductal structures involved near the intraductal lesion 
causing the pathologic discharge, as well as lesions located in the 
peripheral ducts (Fig. 5). 
Peripheral Compression Technique
The nipple or areolar tissues may hinder the detection of lesions due 
to acoustic shadowing, so techniques for maneuvering the nipple 
area to reduce the shadowing helps in visualizing subareolar ductal 
structures. The transducer is positioned radially, parallel to the long 
axis of the diseased duct. Compression is then applied to the lateral 
end of the transducer, flattening out the nipple-areolar area and 
C
Fig. 6. Peripheral compression technique. 
In scans of the subareolar region, the protuberance of the nipple 
produces acoustic shadowing that interferes with clear imaging 
(A). As the intraductal lesion is located, the transducer is positioned 
radially, parallel to the long axis of the diseased duct (A, arrows). 
Compression is then applied first at the distal end of the transducer 
(B, curved arrow), and then at the proximal end of the transducer, 
flattening out the nipple (B, straight arrow). Finally, the transducer is 
slid towards the nipple (C, straight arrow), bending the nipple over 
to the other side (C, curved arrow). 
A B
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positioned in the radial axis, the performer applies compression to 
the nipple region with both the transducer and the free hand not 
used for scanning (Fig. 8). The transducer is slid distally to include 
the nipple, and changes in the targeted duct reveal whether the 
lesion is a true mass or secretory debris. 
       
Dynamic Maneuvers Using Doppler Imaging 
Another technique that can be used to distinguish between true 
intraductal masses and secretory material is the use of Doppler 
images. Dilated ductal structures filled with secretory materials easily 
collapse when external compression is applied, and displacement 
and/or changes in the echogenicity of such materials can be seen on 
real-time US imaging, whereas the location and US characteristics 
of intraductal masses do not change due to compression. When 
Doppler scans are applied, the displacement of intraductal debris 
produces Doppler signals, as the secretory materials swish back and 
forth according to the alternating compression and release caused 
by applying the probe (Fig. 9). 
Management of Women with Pathologic 
Nipple Discharge
At present, the management of women with pathologic nipple 
discharge varies across institutions, and there are no solid data 
regarding which clinical or radiological features accurately 
distinguish malignancies from lesions with a benign etiology [6,7]. 
Fig. 7. Rolled-nipple technique. With the transducer positioned 
parallel to the long axis of the duct under investigation, the index 
finger of the free hand of the performer is positioned at the opposite 
side of the nipple. By sliding the transducer towards the nipple 
(straight arrow), the nipple is gradually rolled over the index finger, 
producing firm adherence of the probe to the skin (curved arrow) 
and flattening out the area that needs visualization.
Fig. 8. Two-handed technique. With the transducer positioned in 
the radial axis, the performer applies compression to the nipple 
region with both the transducer and the free hand not used for 
scanning (straight arrow). The transducer is slid distally to include 
the nipple (curved arrow), and changes in the targeted duct reveal 
whether the lesion is a true mass or secretory debris. 
Fig. 9. Dynamic maneuvers using Doppler imaging. 
As alternating compression (A, arrows) and release (B, arrows) is applied with the ultrasonography probe, the swishing movements of 
the intraductal contents moving back and forth generate Doppler signals, confirming the presence of secretory material rather than true 
intraductal masses. 
A B
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Among the methods of evaluating patients with pathologic nipple 
discharge, breast US has the major advantage of enabling imaging-
guided percutaneous biopsy, which is less invasive than surgical 
excision and facilitates making a preoperative diagnosis that 
substantially affects decision-making about management. Duct 
excision is an invasive procedure that can be difficult in patients in 
whom the affected duct cannot be localized or if the affected duct is 
located posteriorly, and has the risk of postoperative complications 
[12]. Since most patients with pathologic nipple discharge ultimately 
have benign conditions, a less invasive diagnostic procedure is more 
favorable for both the patient and clinician. Based on the pathologic 
diagnosis on US-guided percutaneous biopsy, conservative follow-
up or subsequent vacuum-assisted excision can be considered 
for patients diagnosed with a benign lesion, while direct curative 
surgery can be planned for patients with a malignancy, avoiding 
additional surgery for diagnostic purposes. 
As the accurate preoperative differential diagnosis of women 
with pathologic nipple discharge is difficult, diagnostic strategies 
combining clinical, radiological, and cytopathologic information have 
been proposed for diagnostic purposes and for planning the further 
management of patients with pathologic nipple discharge (Fig. 
10) [6,16,20]. Among the causes of pathologic nipple discharge, 
intraductal papillomas, mostly in solitary form, are known to be the 
most common cause of pathologic nipple discharge [21]. Intraductal 
papilloma is part of a spectrum of papillary neoplasms ranging 
from benign papillomas to papillary carcinoma [22]. Distinguishing 
malignant papillary neoplasms from benign lesions is very difficult, 
even with additional immunohistochemistry staining of a biopsy 
specimen [23], and the significance of papillary neoplasm as a risk 
for breast cancer and the proper management of such neoplasms 
are still under debate. The rate at which papillomas are upgraded to 
malignancies after surgical excision has been reported to be 5%-
21% [24-28], and although various factors such as older age, size, 
and the presence of suspicious US features have been reported to 
predict such an upgrade, no solid evidence exists regarding which 
factors can be used to predict the diagnosis of benign papillomas. 
Based on these upgrade rates, most studies support complete 
surgical excision after diagnosis [24-28]. Still, more than 80% of 
these masses will be confirmed as benign; therefore, more and more 
studies have reported the use of less invasive excision strategies, 
such as US-guided vacuum-assisted excision, for benign papillomas 
[22,29-33]. 
In the evaluation of patients with pathologic nipple discharge, it 
is not rare to encounter patients with no specific findings on any 
sort of examination. Based on the low risk of underlying malignancy 
(0%-5%), several recent studies have proposed conservative follow-
Fig. 10. Diagram showing the workflow for managing women with nipple discharge. US, ultrasonography; VAB, vacuum-assisted biopsy; 
MRI, magnetic resonance imaging.
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up for patients with a physical examination suggesting a benign 
condition, negative mammography results, and negative features 
on breast US [3,10,16,32]. Close observation and regular check-
up with mammography and US for these patients are warranted; 
approximately 80% of cases of pathologic nipple discharge resolve 
spontaneously within 2 years in patients with a benign etiology [6]. 
If pathologic nipple discharge is persistent or recurrent after 2 years 
of monitoring or if the patient is unable to follow the monitoring 
schedule, duct exploration or excision must be considered to detect 
a malignancy that is occult on mammography or US [3,12,31,32]. 
In addition, using additional imaging modalities such as breast MRI, 
with its high sensitivity in detecting occult malignancies [12,14,34], 
or US elastography [35] has been proposed since they may enable 
localization and/or provide further information regarding the 
causative lesion. However, at present, no strict guidelines exist 
regarding the evaluation or management of patients with pathologic 
nipple discharge, and large prospective studies are warranted to 
develop reasonable guidelines for these patients. 
Summary
Nipple discharge results from a range of causes, which may be 
either physiologic or pathologic. Combining the clinical, radiological, 
and cytopathologic features of the patient may be useful for 
predicting malignancy in these patients. Breast US enables the 
visualization of the ductal structure and intraductal causes of 
pathologic nipple discharge, and facilitates a subsequent imaging-
guided percutaneous biopsy. Being familiar with the various US 
techniques that assist in the detailed visualization of subareolar 
ductal structures is helpful for accurately detecting and diagnosing 
lesions. Further prospective studies are warranted to establish 
standard guidelines for the management of patients with pathologic 
nipple discharge. 
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